Home
Market Capitalization of Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals Ltd
NSE: EMCURE
Market Cap
Key Highlights
- The Market Cap of Emcure Pharmaceuticals Ltd is ₹ 20322 crore as of 28 Mar 25 .
- The Latest Trading Price of Emcure Pharmaceuticals Ltd is ₹ 1085 as of 01 Apr 09:52 .

Emcure Pharmaceuticals Ltd
NSE: EMCURE
Share Price
Market Price of Emcure Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
28 Mar 2025 | 1072.8 |
27 Mar 2025 | 1046.15 |
26 Mar 2025 | 1024.65 |
25 Mar 2025 | 1006.45 |
24 Mar 2025 | 1061.75 |
21 Mar 2025 | 1029 |
20 Mar 2025 | 1001.05 |
19 Mar 2025 | 932.45 |
18 Mar 2025 | 937.7 |
17 Mar 2025 | 927.2 |
BlinkX Score for Emcure Pharmaceuticals Ltd
Asset Value vs Market Value of Emcure Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Emcure Pharmaceuticals Ltd
Historical P/E Ratio of Emcure Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Emcure Pharmaceuticals Ltd
Historical Revenue of Emcure Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Emcure Pharmaceuticals Ltd
Historical EBITDA of Emcure Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Emcure Pharmaceuticals Ltd
Historical Net Profit of Emcure Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Emcure Pharmaceuticals Ltd
Dividend Payout Over Time
About Emcure Pharmaceuticals Ltd
- Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
- Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
- They are a research and development driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics, which has enabled to reach target markets across over 70 countries, with a strong presence in India, Europe and Canada.
Emcure Pharmaceuticals Ltd News Hub
Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL
Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs
Read more
13 Aug 24
Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities
Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigned to bank
Read more
13 Aug 24
Emcure Pharmaceuticals consolidated net profit rises 10.48% in the June 2024 quarter
Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended June 2024 a
Read more
14 Aug 24
Emcure Pharmaceuticals to declare Quarterly Result
Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 202
Read more
10 Aug 24